64 related articles for article (PubMed ID: 20223138)
1. Trends in the age of hospitalized patients with urological cancers: A 17-year experience.
Ishii N; Hatakeyama S; Miura H; Tanaka R; Oishi T; Horiguchi H; Hosogoe S; Fujita N; Iwamura H; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
Int J Urol; 2023 Jul; 30(7):572-578. PubMed ID: 36941076
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
Lu K; Chiu KY
Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Outcomes of De Novo Genitourinary Malignancy in Solid Organ Transplant Recipients at the University of Minnesota.
Cleveland B; Gardeck A; Holten M; Jiang S; Jackson S; Pruett T; Warlick C
Transplant Proc; 2023 Nov; 55(9):2027-2034. PubMed ID: 37775402
[TBL] [Abstract][Full Text] [Related]
4. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
5. Native Kidney Renal Cell Carcinoma in Renal Allograft Transplant Patients - Our Experience.
Survase P; Agrawal S; Singh A; Sabnes R; Desai M
J Kidney Cancer VHL; 2024; 11(1):69-73. PubMed ID: 38765864
[TBL] [Abstract][Full Text] [Related]
6. SGLT2 inhibition and three urological cancers: Up-to-date results.
Lin L; Ning K; Xiang L; Peng L; Li X
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3797. PubMed ID: 38523292
[TBL] [Abstract][Full Text] [Related]
7. [Urogenital tumors following kidney transplantation-monocentric analysis of incidences and overview of urological preventive measures].
Putz J; Kestel V; Herout R; Borkowetz A; Leike S; Thomas C; Baunacke M
Urologie; 2024 Apr; 63(4):341-350. PubMed ID: 38512472
[TBL] [Abstract][Full Text] [Related]
8. Impact of newly diagnosed prostate cancer at time of evaluation for renal transplantation.
Poinard F; Bessede T; Barrou B; Drouin S; Karam G; Branchereau J; Alezra E; Thuret R; Verhoest G; Goujon A; Millet C; Boissier R; Delaporte V; Sallusto F; Prudhomme T; Boutin JM; Culty T; Timsit MO
Clin Transplant; 2023 Sep; 37(9):e14998. PubMed ID: 37138463
[TBL] [Abstract][Full Text] [Related]
9. History of urological malignancies before kidney transplantation, oncological outcome on the long term.
Boissier R; Hidalgo R; Rodríguez Faba O; Territo A; Subiela JD; Huguet J; Sánchez-Puy A; Gallioli A; Vanacore D; Mercade A; Martinez C; Palou J; Guirado L; Breda A
Actas Urol Esp (Engl Ed); 2021 Jun; ():. PubMed ID: 34172308
[TBL] [Abstract][Full Text] [Related]
10. Clinical Course of Candidate Renal Transplant Recipients Diagnosed With Prostate Cancer During Pre-transplant Screening Test.
Kobari Y; Iizuka J; Nagahisa C; Minoda R; Unagami K; Yoshida K; Hirai T; Shimizu T; Ishida H; Takagi T
In Vivo; 2024; 38(1):496-499. PubMed ID: 38148097
[TBL] [Abstract][Full Text] [Related]
11. De novo malignancy after liver transplantation: a single-center experience of 14 cases.
Gao PJ; Gao J; Li Z; Hu ZP; Zhu JY
Ann Surg Treat Res; 2015 Apr; 88(4):222-8. PubMed ID: 25844357
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous living donor orthotopic renal transplantation and bilateral nephrectomy for recurrent renal cell carcinoma and renal failure: case report and review of literature.
Novotny R; Marada T; Chlupac J; Viklicky O; Fronek J
Res Rep Urol; 2018; 10():69-73. PubMed ID: 30237991
[TBL] [Abstract][Full Text] [Related]
13. Malignancies in a renal transplant population: The St. Michael's Hospital experience.
Saleeb R; Faragalla H; Yousef GM; Stewart R; Streutker CJ
Urol Ann; 2016; 8(2):163-7. PubMed ID: 27141185
[TBL] [Abstract][Full Text] [Related]
14. Urothelial cancers after renal transplantation.
Cox J; Colli JL
Int Urol Nephrol; 2011 Sep; 43(3):681-6. PubMed ID: 21373847
[TBL] [Abstract][Full Text] [Related]
15. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
[TBL] [Abstract][Full Text] [Related]
17. Genitourinary tumor following kidney transplantation: a multicenter study.
Einollahi B; Simforoosh N; Lessan-Pezeshki M; Basiri A; Nafar M; Pour-Reza Gholi F; Firouzan A; Ahmadpour P; Makhdomi K; Ghafari A; Taghizadeh A; Tayebi Khosroshahi H
Transplant Proc; 2009 Sep; 41(7):2848-9. PubMed ID: 19765454
[TBL] [Abstract][Full Text] [Related]
18. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
19. [De novo urologic tumors in kidney transplant patients].
Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
